We therefore probed the involvement of the OMA1/OPA1 pathway in a mouse sarcoma model and tested whether the level of OMA1 and OPA1 expressions was associated with clinical outcome and immune variables in human soft tissue sarcomas (STS). The gene discussed is OPA1; the disease is sarcoma.